Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy

Lipids disorder is the principal cause of atherosclerosis and may present with several forms, according to blood lipoprotein prevalence. One of the most common forms is combined dyslipidemia, characterized by high levels of triglycerides and low level of high-density lipoprotein. Single lipid-loweri...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vasc Health Risk Manag
Egile Nagusiak: Tarantino, Nicola, Santoro, Francesco, De Gennaro, Luisa, Correale, Michele, Guastafierro, Francesca, Gaglione, Antonio, Di Biase, Matteo, Brunetti, Natale Daniele
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2017
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5317328/
https://ncbi.nlm.nih.gov/pubmed/28243111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S95044
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak